Who is sponsoring NCT04692402?

NCT04692402 is sponsored by Paul Ong.

What drugs are being tested in NCT04692402?

Interventions in NCT04692402: Solitaire™ thrombus retrieval device.

What condition does NCT04692402 study?

NCT04692402 studies Refractory Thrombus in Patients With Acute Coronary Syndrome.

Is NCT04692402 still recruiting?

NCT04692402 is currently status unknown. Last updated 31 December 2020.

Last reviewed 2020-12-31 · How we verify

NCT04692402: Solitaire

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility Trial Evaluating Efficacy and Safety of Solitaire™ Thrombus Retrieval Device in the Management of Refractory Thrombus in Patients With Acute Coronary Syndrome

Status unknown NA Last updated 31 December 2020

What this trial tests

NA trial testing Solitaire™ thrombus retrieval device in Refractory Thrombus in Patients With Acute Coronary Syndrome in 51 participants. Status unknown.

Timeline

16 July 2019

Primary endpoint
30 June 2022

30 September 2022

Quick facts

Lead sponsor	Paul Ong
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	51
Start date	16 July 2019
Primary completion	30 June 2022
Estimated completion	30 September 2022
Sites	5 locations across Singapore

Drugs / interventions tested

Solitaire™ thrombus retrieval device

Conditions studied

Refractory Thrombus in Patients With Acute Coronary Syndrome — all drugs for Refractory Thrombus in Patients With Acute Coronary Syndrome →

Sponsor

Paul Ong

Who can join

Adults 22 to 80, any sex, with Refractory Thrombus in Patients With Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed as a multicentre open label prospective feasibility trial to capture preliminary efficacy and safety information on Solitaire device to plan an appropriate pivotal study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy and Safety of Solitaire Revascularization Device in Managing Refractory Thrombus in Acute Coronary Syndrome.
Khoo DZL, Lee DJH, Acharyya S, Pooh HC, et al · · 2025 · PMID 41498002 · DOI 10.1016/j.jscai.2025.104004

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04692402 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Paul Ong
Last refreshed: 31 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04692402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing